These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32580391)
1. Nitric Oxide Production and Fc Receptor-Mediated Phagocytosis as Functional Readouts of Macrophage Activity upon Stimulation with Inactivated Poultry Vaccines In Vitro. van den Biggelaar RH; van Eden W; Rutten VP; Jansen CA Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32580391 [TBL] [Abstract][Full Text] [Related]
2. Macrophage Activation Assays to Evaluate the Immunostimulatory Capacity of van den Biggelaar RHGA; van Eden W; Rutten VPMG; Jansen CA Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33182624 [TBL] [Abstract][Full Text] [Related]
3. Antigen quantification as in vitro alternative for potency testing of inactivated viral poultry vaccines. Maas RA; de Winter MP; Venema S; Oei HL; Claassen IJ Vet Q; 2000 Oct; 22(4):223-7. PubMed ID: 11087135 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of chicken bone marrow-derived dendritic cells in response to an inactivated IBV + NDV poultry vaccine. van den Biggelaar RHGA; van der Maas L; Meiring HD; Pennings JLA; van Eden W; Rutten VPMG; Jansen CA Sci Rep; 2021 Jun; 11(1):12666. PubMed ID: 34135356 [TBL] [Abstract][Full Text] [Related]
5. Induction of IBV strain-specific neutralizing antibodies and broad spectrum protection in layer pullets primed with IBV Massachusetts (Mass) and 793B vaccines prior to injection of inactivated vaccine containing Mass antigen. de Wit JJS; Malo A; Cook JKA Avian Pathol; 2019 Apr; 48(2):135-147. PubMed ID: 30518248 [TBL] [Abstract][Full Text] [Related]
6. Laboratory methods for assessing and licensing influenza vaccines for poultry. Swayne DE Methods Mol Biol; 2014; 1161():185-98. PubMed ID: 24899430 [TBL] [Abstract][Full Text] [Related]
7. Validation study to evaluate the reproducibility of a candidate in vitro potency assay of newcastle disease vaccines and to establish the suitability of a candidate biological reference preparation. Claassen I; Maas R; Oei H; Daas A; Milne C Pharmeuropa Bio; 2004 Dec; 2004(1):1-15. PubMed ID: 15659281 [TBL] [Abstract][Full Text] [Related]
8. Non-thermal plasma for inactivated-vaccine preparation. Wang G; Zhu R; Yang L; Wang K; Zhang Q; Su X; Yang B; Zhang J; Fang J Vaccine; 2016 Feb; 34(8):1126-32. PubMed ID: 26529075 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens. Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723 [TBL] [Abstract][Full Text] [Related]
10. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines. Vagnozzi A; García M; Riblet SM; Zavala G Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841 [TBL] [Abstract][Full Text] [Related]
12. Antigen content of inactivated Newcastle disease oil emulsion vaccines as an in vitro indicator of potency. Maas R; van Diepen M; Komen M; Oei H; Claassen I Dev Biol (Basel); 2002; 111():313-8. PubMed ID: 12678255 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens. Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431 [TBL] [Abstract][Full Text] [Related]
14. A bacterial ghost improves the immunological efficacy of a Newcastle disease virus inactivated vaccine. Si W; Yu S; Liu H; Wang C; Chen L; Wang G; Wu J; Liu S Vet Microbiol; 2017 May; 203():189-195. PubMed ID: 28619143 [TBL] [Abstract][Full Text] [Related]
15. Vaccination of chickens against Newcastle disease with live and inactivated Newcastle disease virus. Winterfield RW; Dhillon AS; Alby LJ Poult Sci; 1980 Feb; 59(2):240-6. PubMed ID: 7413554 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza. Zhao J; Yang H; Xu H; Ma Z; Zhang G Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119 [TBL] [Abstract][Full Text] [Related]
17. Protection of chickens after live and inactivated virus vaccination against challenge with nephropathogenic infectious bronchitis virus PA/Wolgemuth/98. Ladman BS; Pope CR; Ziegler AF; Swieczkowski T; Callahan CJ; Davison S; Gelb J Avian Dis; 2002; 46(4):938-44. PubMed ID: 12495055 [TBL] [Abstract][Full Text] [Related]
18. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken. Mehrabanpour M Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590 [TBL] [Abstract][Full Text] [Related]
19. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens. Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508 [TBL] [Abstract][Full Text] [Related]
20. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus. Lone NA; Spackman E; Kapczynski D Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]